首页> 外国专利> REDUCTION OF HYPERGLYCEMIA BY ADMINISTRATION OF DIMETHYLFORMAMIDE FOR TREATING HYPERGLYCEMIC CONDITIONS, INCLUDING DIABETES MELLITUS

REDUCTION OF HYPERGLYCEMIA BY ADMINISTRATION OF DIMETHYLFORMAMIDE FOR TREATING HYPERGLYCEMIC CONDITIONS, INCLUDING DIABETES MELLITUS

机译:通过使用二甲基甲酰胺来治疗高血糖症(包括糖尿病)来减少高血糖症

摘要

A treatment for a hyperglycemic condition, including diabetes mellitus, includes the step of administering to a human being dimethylformamide ("DMF"), which has the chemical structural formula (I). DMF can be administered to the human patient in a wide variety of ways, however it is preferable that the administration of DMF be performed orally and the dose of DMF could be combined with numerous inert substances known to the prior art, such as a sugarless fruit juice concentrate. The preferred daily dosage of DMF administered to a person would be about 0.041 mg/kg body weight to about 1.23 mg/kg of body weight of the person.
机译:对包括糖尿病在内的高血糖病症的治疗包括对人施用具有化学结构式(I)的二甲基甲酰胺(“ DMF”)的步骤。 DMF可以多种方式施用于人类患者,但是优选DMF口服施行,并且DMF的剂量可以与现有技术已知的多种惰性物质如无糖水果混合使用浓缩果汁。给予人的DMF的优选每日剂量为约0.041mg / kg体重至约1.23mg / kg人体重。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号